Navigation Links
Sidekick™ Blood Glucose Testing System

ProductsSidekick™ Blood Glucose Testing System
Company Home Diagnostics, Inc.
Item Sidekick™ Blood Glucose Testing System
Features 
  • No Coding just start testing
  • 1 uL blood sample less blood means less pain
  • 2 simple steps just insert strip and test
  • Less than 10 seconds fast results mean more convenience
  • Forearm or Fingertip more choices means greater comfort
  • Low Cost The Sidekick™ Testing System costs much less than a meter and test strips purchased separately
Description The Sidekick Testing System is the smallest blood glucose testing system available. The Sidekick Testing System is there when you need it in your backpack or briefcase, your sports bag or suitcase, or simply in your purse or pocket.* Its small size makes it convenient to take wherever you go. And, because it's so convenient it's easier for you to test more often so you can better monitor and manage your diabetes.
Info Home Diagnostics, Inc.
Customer Service: (888) 777-7357
Web site: http://www.homediagnosticsinc.com

Related medicine products :

1. Roche OMNI C Blood Gas Analyzer
2. RapidLab 248 Blood Gas Analyzer
3. Rapidlab 348 Blood Gas Analyzer
4. ABL700 Blood gas analyzer
5. ABL77 Blood Gas Analyzer
6. ABL555 Blood gas analyzer
7. ABL5 Blood gas analyzer
8. Automated Blood Coagulation Analyzer
9. Blood Coagulation Analyzer CG Series
10. Series 590 Low Cost Whole Blood Aggregometers
11. Tetrachrome Blood Stain
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm.
Cross action, round handle, maximum opening 2.8 mm.
Cross action, round handle, maximum opening 2.8 mm.
Dodick nucleus cracker cross-action longitudinally serrated paddle shaped jaws for cracking the nucleus through a 3.0 mm incision.
Medicine Products:
(Date:5/16/2008)...an Society of Clinical Oncology meeting in Chicago...n about 25 percent of patients with colon cancer a...lorectal cancers will be staged. , This new st...pulation-based statistic registries from 1992 to 2... outcomes of patients with positive nodes (Stage I...
(Date:5/16/2008)...ining of the uterus (submucosal) are more likely t...ery embolization (UAE) but usually dont cause majo...e study included 49 patients with 140 fibroids who.... The study found that 39 of these were submucosal... after UAE, said Sachit Verma, MD, lead author of ...
(Date:5/16/2008)...t 10:15 a.m. Eastern Time, VANCOUVER, May 16 /PRN...on (TSX: RBM, OTCBB: RPBIF) today announced that S... to present at the Rodman & Renshaw,5th Annual Glo...:15 a.m.,EDT., A live web cast of the presentatio...http://www.responsebio.com/newsroom_events_calenda...
(Date:5/16/2008)... most from chemo after surgery, study says , ...of 15 genes may help determine which patients with...ience a recurrence and, therefore, benefit the mos...xtension, the same genetic signature may also iden...ncer who would be able to forego chemotherapy. ,...
Breaking Medicine News(10 mins):Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3
...oft drinks, on sale in Britain and France have rev...zene. The levels found// are 8 times the permissib...ing to the Food Standards Agency, involved in the ...emical, produced during partial combustion of carb...
...ision of household chores or other factors can mak...only sole factor that contribute to a woman's mari...engagement// and commitment. The following is the ... and Steven L. Nock, from the University of Virgin...
...orld Health Organization to investigate the possib...ect outbreaks of bird flu//. They are already read...s where the investigation with bird flu virus is a...ing questions in the House of Commons about the UK...
...es Secretary Michael Leavitt said that the lethal ...ich will soon infect wild birds// and domesticated...ssional panel told the senators that it's just a m...ds and possibly poultry flocks would contract the ...
Other Medicine News:Health News:High Levels Of Cancer Chemical Found In Soft Drinks 2Health News:Emotional Engagement of Husband - A Final Answer To What Women Want 2
(Date:5/15/2008)...BONITA SPRINGS, Fla., May 15 /- Tigri...ion of a Cooperative Research and,Development Agre...NCI) to,collaborate on clinical and preclinical de... Phase I development. AFP-464 is converted to,meta... p53 activation and,apoptosis., This is part of a...
(Date:5/15/2008)...iderable Opportunity Remains for an Antiplatelet T...leeding than the Combination of Plavix/Iscover ...ion Resources, WALTHAM, Mass., May 15 /PRNewswire...g research and advisory firms for pharmaceutical a...i Lilly,s Effient offers,improvement in patient co...
(Date:5/15/2008)...p Line Data Expected soon after CEA Trial data rep... -, SAN FRANCISCO, May 15 /PRNewswire-FirstC..., a biotechnology company focused on the developme...r disease, announced today that,it has completed p...ACS),study. The ACS study is one of three Phase 2 ...
(Date:5/15/2008)... Data Presented at the 21st Annual Meeting of The ...y/Oncology (ASPHO) Meeting -, IRVINE, Calif., May...e,Company) (Nasdaq: IDMI ) today announced the pr...cess program evaluating mifamurtide (L-MTP-PE) in,...rogression of,osteosarcoma, a rare and often fatal...
Breaking Medicine Technology:Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit 2764 1The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit 2764 2The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit 2764 3The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit 2764 4BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondary 2760 1BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondary 2760 2Modified Atkins diet can cut epileptic seizures in adults 10224 1Modified Atkins diet can cut epileptic seizures in adults 10224 2Embryos Discarded During IVF Create Stem Cell Lines 10220 1Embryos Discarded During IVF Create Stem Cell Lines 10220 2